BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1604 related articles for article (PubMed ID: 19874988)

  • 1. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of peripheral sympathetic nervous system control in congestive heart failure.
    Cohn JN
    Circulation; 1990 Aug; 82(2 Suppl):I59-67. PubMed ID: 1973641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system.
    Packer M
    Postgrad Med; 1988 Feb; Spec No():96-103. PubMed ID: 2894667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-adrenergic component of the sympathetic nervous system in congestive heart failure.
    Leier CV; Binkley PF; Cody RJ
    Circulation; 1990 Aug; 82(2 Suppl):I68-76. PubMed ID: 2164897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological mechanisms underlying the effects of beta-adrenergic agonists and antagonists on functional capacity and survival in chronic heart failure.
    Packer M
    Circulation; 1990 Aug; 82(2 Suppl):I77-88. PubMed ID: 1973643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists.
    Packer M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensatory changes of sympathetic tone, the renin-angiotensin-aldosterone system, vasopressin, and ANF as potential therapeutic targets in congestive heart failure.
    van Zwieten PA
    Z Kardiol; 1988; 77 Suppl 5():67-76. PubMed ID: 2975894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroendocrine changes in chronic cardiac insufficiency].
    Jaeger P; Cohen-Solal A; Dahan M; Juliard JM; Charlier P; Gourgon R
    Arch Mal Coeur Vaiss; 1988 Feb; 81(2):157-62. PubMed ID: 2967069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic changes in cardiac failure].
    Gibelin P
    Ann Cardiol Angeiol (Paris); 1992 Dec; 41(10):571-9. PubMed ID: 1300920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial catecholamines and the pathophysiology of heart failure.
    Daly PA; Sole MJ
    Circulation; 1990 Aug; 82(2 Suppl):I35-43. PubMed ID: 2197023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?].
    Lohmann FW
    Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapeutic profile of ibopamine in heart failure.
    Taylor SH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of inodilators.
    Dei Cas L; Metra M; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of beta-blockade therapy in treatment of congestive heart failure.
    Sobotka PA; Gunnar RM
    Clin Cardiol; 1992 Sep; 15(9):630-5. PubMed ID: 1356677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral factors in chronic heart failure. A review.
    Kölbel F
    Cor Vasa; 1992; 34(1):67-70. PubMed ID: 1337731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the adrenergic and renin-angiotensin-aldosterone-systems.
    van Zwieten PA; de Jonge A
    Postgrad Med J; 1986; 62 Suppl 1():23-7. PubMed ID: 3534860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrinology of cardiac failure. Pathophysiologic aspects--hemodynamics.
    Persson S
    Acta Med Scand Suppl; 1986; 707():7-14. PubMed ID: 2943144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohumoral mechanisms in heart failure: role in pathogenesis, therapy, and drug tolerance.
    Dzau VJ; Hollenberg NK; Williams GH
    Fed Proc; 1983 Dec; 42(15):3162-9. PubMed ID: 6357858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.